METASTATIC CHOLANGIOCARCINOMA
Clinical trials for METASTATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 15 people with advanced bile duct cancer that has spread or come back. The drug works like a smart bomb, attaching to a protein on cancer cells and delivering a toxic payload to kill them. The main goal is to see how many pa…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 17, 2026 02:20 UTC
-
Triple threat against tough cancers: drug combo plus radiation shows promise
Disease control OngoingThis study tests a new combination of two drugs (peposertib and avelumab) plus a special type of radiation for people with advanced solid tumors or bile duct cancers that have spread. The goal is to find the safest dose and see if the treatment can shrink tumors. About 103 adults…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis study tests a new drug called pevonedistat, given alone or with standard chemotherapy (paclitaxel and carboplatin), in people with advanced bile duct cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors. About 40 adults who hav…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 24, 2026 16:05 UTC